Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 231

1.

Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity.

Goulet ML, Olagnier D, Xu Z, Paz S, Belgnaoui SM, Lafferty EI, Janelle V, Arguello M, Paquet M, Ghneim K, Richards S, Smith A, Wilkinson P, Cameron M, Kalinke U, Qureshi S, Lamarre A, Haddad EK, Sekaly RP, Peri S, Balachandran S, Lin R, Hiscott J.

PLoS Pathog. 2013;9(4):e1003298. doi: 10.1371/journal.ppat.1003298. Epub 2013 Apr 25.

PMID:
23633948
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response.

Olagnier D, Scholte FE, Chiang C, Albulescu IC, Nichols C, He Z, Lin R, Snijder EJ, van Hemert MJ, Hiscott J.

J Virol. 2014 Apr;88(8):4180-94. doi: 10.1128/JVI.03114-13. Epub 2014 Jan 29.

PMID:
24478443
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.

Kulkarni RR, Rasheed MA, Bhaumik SK, Ranjan P, Cao W, Davis C, Marisetti K, Thomas S, Gangappa S, Sambhara S, Murali-Krishna K.

J Virol. 2014 Dec;88(24):13990-4001. doi: 10.1128/JVI.02273-14. Epub 2014 Sep 24.

PMID:
25253340
[PubMed - indexed for MEDLINE]
4.

5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.

Ranjan P, Jayashankar L, Deyde V, Zeng H, Davis WG, Pearce MB, Bowzard JB, Hoelscher MA, Jeisy-Scott V, Wiens ME, Gangappa S, Gubareva L, García-Sastre A, Katz JM, Tumpey TM, Fujita T, Sambhara S.

Virol J. 2010 May 21;7:102. doi: 10.1186/1743-422X-7-102.

PMID:
20492658
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The critical role of Notch ligand Delta-like 1 in the pathogenesis of influenza A virus (H1N1) infection.

Ito T, Allen RM, Carson WF 4th, Schaller M, Cavassani KA, Hogaboam CM, Lukacs NW, Matsukawa A, Kunkel SL.

PLoS Pathog. 2011 Nov;7(11):e1002341. doi: 10.1371/journal.ppat.1002341. Epub 2011 Nov 3.

PMID:
22072963
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

β-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-κB signaling.

Hillesheim A, Nordhoff C, Boergeling Y, Ludwig S, Wixler V.

Cell Commun Signal. 2014 Apr 26;12:29. doi: 10.1186/1478-811X-12-29.

PMID:
24767605
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Hepatitis C virus reveals a novel early control in acute immune response.

Arnaud N, Dabo S, Akazawa D, Fukasawa M, Shinkai-Ouchi F, Hugon J, Wakita T, Meurs EF.

PLoS Pathog. 2011 Oct;7(10):e1002289. doi: 10.1371/journal.ppat.1002289. Epub 2011 Oct 13.

PMID:
22022264
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA.

Konno H, Yamamoto T, Yamazaki K, Gohda J, Akiyama T, Semba K, Goto H, Kato A, Yujiri T, Imai T, Kawaguchi Y, Su B, Takeuchi O, Akira S, Tsunetsugu-Yokota Y, Inoue J.

PLoS One. 2009 May 25;4(5):e5674. doi: 10.1371/journal.pone.0005674.

PMID:
19479062
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Influenza A(H1N1)pdm09 virus suppresses RIG-I initiated innate antiviral responses in the human lung.

Wu W, Zhang W, Booth JL, Metcalf JP.

PLoS One. 2012;7(11):e49856. doi: 10.1371/journal.pone.0049856. Epub 2012 Nov 21.

PMID:
23185463
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The alpha/beta interferon receptor provides protection against influenza virus replication but is dispensable for inflammatory response signaling.

Goodman AG, Zeng H, Proll SC, Peng X, Cillóniz C, Carter VS, Korth MJ, Tumpey TM, Katze MG.

J Virol. 2010 Feb;84(4):2027-37. doi: 10.1128/JVI.01595-09. Epub 2009 Nov 25.

PMID:
19939913
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.

Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, García-Sastre A, Katze MG, Gale M Jr.

J Virol. 2008 Jan;82(1):335-45. Epub 2007 Oct 17.

PMID:
17942531
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling.

Liao S, Bao X, Liu T, Lai S, Li K, Garofalo RP, Casola A.

J Gen Virol. 2008 Aug;89(Pt 8):1978-86. doi: 10.1099/vir.0.2008/000778-0.

PMID:
18632970
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia.

Crotta S, Davidson S, Mahlakoiv T, Desmet CJ, Buckwalter MR, Albert ML, Staeheli P, Wack A.

PLoS Pathog. 2013;9(11):e1003773. doi: 10.1371/journal.ppat.1003773. Epub 2013 Nov 21.

PMID:
24278020
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction.

Fan L, Briese T, Lipkin WI.

J Virol. 2010 Feb;84(4):1785-91. doi: 10.1128/JVI.01362-09. Epub 2009 Dec 9.

PMID:
20007272
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Activation of toll-like receptor signaling pathway for protection against influenza virus infection.

Wong JP, Christopher ME, Viswanathan S, Karpoff N, Dai X, Das D, Sun LQ, Wang M, Salazar AM.

Vaccine. 2009 May 26;27(25-26):3481-3. doi: 10.1016/j.vaccine.2009.01.048. Epub 2009 Feb 5.

PMID:
19200852
[PubMed - indexed for MEDLINE]
16.

LGP2 downregulates interferon production during infection with seasonal human influenza A viruses that activate interferon regulatory factor 3.

Malur M, Gale M Jr, Krug RM.

J Virol. 2012 Oct;86(19):10733-8. doi: 10.1128/JVI.00510-12. Epub 2012 Jul 25.

PMID:
22837208
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A Kampo (traditional Japanese herbal) medicine, Hochuekkito, pretreatment in mice prevented influenza virus replication accompanied with GM-CSF expression and increase in several defensin mRNA levels.

Dan K, Akiyoshi H, Munakata K, Hasegawa H, Watanabe K.

Pharmacology. 2013;91(5-6):314-21. doi: 10.1159/000350188. Epub 2013 Jun 19.

PMID:
23796966
[PubMed - indexed for MEDLINE]
Free Article
18.

Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling.

Kalali BN, Köllisch G, Mages J, Müller T, Bauer S, Wagner H, Ring J, Lang R, Mempel M, Ollert M.

J Immunol. 2008 Aug 15;181(4):2694-704.

PMID:
18684960
[PubMed - indexed for MEDLINE]
Free Article
19.

Double-stranded RNA induces biphasic STAT1 phosphorylation by both type I interferon (IFN)-dependent and type I IFN-independent pathways.

Dempoya J, Matsumiya T, Imaizumi T, Hayakari R, Xing F, Yoshida H, Okumura K, Satoh K.

J Virol. 2012 Dec;86(23):12760-9. doi: 10.1128/JVI.01881-12. Epub 2012 Sep 12.

PMID:
22973045
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.

Kubota T, Matsuoka M, Chang TH, Tailor P, Sasaki T, Tashiro M, Kato A, Ozato K.

J Biol Chem. 2008 Sep 12;283(37):25660-70. doi: 10.1074/jbc.M804479200. Epub 2008 Jul 17.

PMID:
18635538
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk